The UCLA Vine Street Clinic (UVSC) was established in 2005 in order to study the diffusion of HIV among methamphetamine user networks. Since that time, it has served as a site for clinical trials, behavioral research, and direct services focusing on the treatment of addiction, HIV prevention, and the intersection of the two. It is unique in its location, bringing the best in academia from UCLA into a transitional neighborhood of predominately working poor, designated as a medically underserved area. The facility includes exam and counseling rooms for patient care, a lab for collection and storage of biological samples, a computer room and group meeting space. Current services available at the clinic are detailed below. For more information or to schedule an appointment, call us at (866) 449-UCLA or email us at email@example.com.
This program provides evidence-based, short-term behavioral health services to patients coping with addictions. Clinicians work closely with patients to develop treatment plans tailored to each individual’s needs with the goal of improving regular daily function, abstaining from substance use, reducing stress and psychological symptoms, and improving relationships with family and friends. Many of the services we offer are carried out by Attending Psychologists who are training advanced graduate students in clinical psychology.
Phase II Randomized Trial of Ibudilast For Methamphetamine Dependence
Following up on the Phase I safety trial, the objective of this study is to test the safety and potential efficacy of ibudilast to treat methamphetamine dependence. The safety and tolerability of ibudilast for the treatment of methamphetamine was tested and pilot data on the medication’s effectiveness was promising. This outpatient study for treatment seeking, methamphetamine-dependent persons is currently being conducted at the UCLA Vine Street Clinic in Hollywood.
Clinical Trial of Varenicline for the Treatment of Methamphetamine Dependence
The goal of this Phase II study is to test the early efficacy of the medication varenicline in treating methamphetamine dependence. The safety and tolerability of varenicline for the treatment of methamphetamine was tested and pilot data on the medication’s effectiveness was promising. This outpatient study for treatment seeking, methamphetamine-dependent persons is currently being conducted at the UCLA Vine Street Clinic in Hollywood.
UCLA/RAND Project Discover
In collaboration with the RAND Corporation, Project Discover is a NIDA-funded study looking at ways young, drug-using Black men who have sex with men (BMSM) who are HIV negative may be managing their choices to avoid HIV by changing their behavior. This approach to studying HIV negative BMSM can help researchers create and implement more realistic and effective interventions this specific demographic group.
HPTN 073: PreExposure Prophylaxis Uptake and Adherence among Black Men who have sex with men (BMSM)
This is a collaborative project of the national HIV Prevention Trials Network (HPTN), protocol #073 (HPTN 073). The trial will test Truvada®, an HIV treatment medication, for pre-exposure prophylaxis (PrEP). PrEP is a new HIV prevention method in which people who are HIV-negative can be prescribed a daily HIV treatment drug to reduce their risk of becoming infected. The FDA approved Truvada® for use as PrEP in 2012. The Los Angeles site will enroll 75 BMSM over a one-year period.
According to a 1992 study published in the Journal of Sexually Transmitted Diseases, using a condom makes sex 10,000 times safer than not using a condom. The UCLA Vine Street Clinic has partnered with LA County to provide free condoms to the public. For more information, click here.